Literature DB >> 24371595

Cytomegalovirus reactivation following chemoradiation for invasive cervical carcinoma.

Matthew Schlumbrecht1, Kevin Grimes2, Jubilee Brown1.   

Abstract

► Cytomegalovirus is an uncommon infectious agent in gynecologic cancer patients. ► Viral causes should be considered in women on chemotherapy with persistent fever.

Entities:  

Keywords:  Chemotherapy; Cytomegalovirus; Fever of unknown origin

Year:  2011        PMID： 24371595      PMCID： PMC3857676          DOI： 10.1016/j.gynor.2011.08.002

Source DB:  PubMed          Journal:  Gynecol Oncol Case Rep        ISSN： 2211-338X


  7 in total

Review 1.  Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy.

Authors:  Shigeru Kusumoto; Yasuhito Tanaka; Ryuzo Ueda; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2010-10-06       Impact factor: 7.527

2.  Regular virologic surveillance showed very frequent cytomegalovirus reactivation in patients treated with alemtuzumab.

Authors:  Winnie W Cheung; Eric Tse; Anskar Y H Leung; Kwok-Yung Yuen; Yok-Lam Kwong
Journal:  Am J Hematol       Date:  2007-02       Impact factor: 10.047

3.  Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004.

Authors:  Sheri Lewis Bate; Sheila C Dollard; Michael J Cannon
Journal:  Clin Infect Dis       Date:  2010-06-01       Impact factor: 9.079

4.  High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for adult T cell leukemia.

Authors:  Masao Ogata; Takako Satou; Rie Kawano; Tetsushi Yoshikawa; Junji Ikewaki; Kazuhiro Kohno; Takeaki Ando; Yasuhiko Miyazaki; Eiichi Ohtsuka; Yoshio Saburi; Hiroshi Kikuchi; Tetsunori Saikawa; Jun-ichi Kadota
Journal:  J Med Virol       Date:  2011-04       Impact factor: 2.327

5.  Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia.

Authors:  Saveria Capria; Giuseppe Gentile; Angela Capobianchi; Luisa Cardarelli; Valentina Gianfelici; Silvia Maria Trisolini; Robin Foà; Pietro Martino; Giovanni Meloni
Journal:  J Med Virol       Date:  2010-07       Impact factor: 2.327

6.  High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy.

Authors:  S Zhong; W Yeo; C Schroder; P K S Chan; W-L Wong; W M Ho; F Mo; B Zee; P J Johnson
Journal:  J Viral Hepat       Date:  2004-01       Impact factor: 3.728

7.  Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy.

Authors:  C-P Kuo; C-L Wu; H-T Ho; C G Chen; S-I Liu; Y-T Lu
Journal:  Clin Microbiol Infect       Date:  2007-12-05       Impact factor: 8.067
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.